Explore By Subject Area   
Return Home
Register Here Menu

Patients as Partners Europe

Date: May 20, 2025 - May 21, 2025

Location: London, UK

Day 2: Wednesday, May 21, 2025
Showing Events in 1 Track from 08:30am to 09:00am
Morning Remarks
8:30AM - 8:50AM
Registration
8:50AM - 9:00AM
Co-Chair Welcome
Co-Chairs:
Victoria DiBiaso, MPH, VP, Head of Patient Informed Development & Health Value Translation, Sanofi
Wafae Iraqi, PharmD, PhD, EMEA, Therapeutic Area Patient Engagement Lead, Johnson & Johnson Innovative Medicine
Sarah Pilkington, Director, Patient Engagement, Parexel
Alfred Samuels, Patient, Advocate and Author
Showing Events in 1 Track from 09:00am to 09:25am
Zeitgeist Discussion
9:00AM - 9:25AM
GSK on Advancing Patient-Centric Medicine Development in a Fireside Discussion
Led By:
Andrew Garvey, Global Patient Advocacy Lead, GSK
Showing Events in 1 Track from 09:25am to 10:25am
Patient Keynote, Perspectives & Collaborations
9:25AM - 9:55AM
Patient Keynote: If I Only Knew This?
Speakers:
Peter DiBiaso, Patient, Advocate
9:55AM - 10:25AM
Patient Journey Perspectives on Aspects of Vital Support
Panelists:
Peter DiBiaso, Patient, Advocate
Daniel Newman, Patient, Advocate
Temi Olonisakin, MD, Patient, Advocate
Alfred Samuels, Patient, Advocate and Author
Showing Events in 1 Track from 10:25am to 11:00am
Morning Networking Break
10:25AM - 11:00AM
Morning Networking Break
Showing Events in 1 Track from 11:00am to 12:05pm
Patient Keynote, Perspectives & Collaborations Continued
11:00AM - 11:25AM
Patient Partnerships in Action: Integrating Patient Expertise into Product Innovation and Development
Speakers:
Lorna Allen, Involvement Manager, Cystic Fibrosis Trust
Rebecca Holmes, PhD, Scientific Director, LifeArc
Connie Takawira, Partnerships Manager, Medicines Discovery Catapult
11:25AM - 11:50AM
Johnson & Johnson Innovative Medicine on an End-to-End Matrix Approach to Patient Advocacy and Engagement
Speakers:
Wafae Iraqi, PharmD, PhD, EMEA, Therapeutic Area Patient Engagement Lead, Johnson & Johnson Innovative Medicine
Beyza Klein, Director, Patient Advocacy R&D, Johnson & Johnson Innovative Medicine
11:50AM - 12:05PM
Open Session
Showing Events in 1 Track from 12:05pm to 12:50pm
Audience Breakout Session
12:05PM - 12:50PM
Mapping the Patient Journey in Clinical Trials
Led By:
Victoria DiBiaso, MPH, VP, Head of Patient Informed Development & Health Value Translation, Sanofi
Alfred Samuels, Patient, Advocate and Author
Showing Events in 1 Track from 12:50pm to 01:45pm
Lunch
12:50PM - 1:45PM
Lunch
Showing Events in 1 Track from 01:50pm to 03:00pm
DCT, DEI & Patient Recruitment Advancements
1:50PM - 2:15PM
GSK on Advances in Decentralized Clinical Trials & Engaging with Patients Digitally
Speaker:
Laura Renton, Manager (Implementation), Digital & Process Optimization, GSK
2:15PM - 2:40PM
Who are Trusted Messengers for Patient Engagement in Real World Data Studies? A Behavioural Science Approach
Speaker:
Sally Dews, Director, Global Patient Advocacy and External Partnerships, Pfizer UK
2:40PM - 3:00PM
Boehringer-Ingelheim on Overcoming Barriers to Global Diverse Recruitment in Colorectal Cancer
Speakers:
Xoli Belgrave, Executive Director, Drug Development Services, Parexel
Bert Santy, Patient & Site Engagement Lead, Boehringer Ingelheim
Nicole Sheahan, President, Global Colon Cancer Association
Showing Events in 1 Track from 03:00pm to 03:30pm
HTA Assessment/Health Technology
3:00PM - 3:30PM
Patient Involvement In Health Technology Assessment Processes – Focus On Training and Capacity Building
Speaker:
Finn McCartney, Project Manager, EUPATI
Showing Events in 1 Track from 03:30pm to 03:35pm
Stretch Break
3:30PM - 3:35PM
Stretch Break
Showing Events in 1 Track from 03:35pm to 04:35pm
Measuring Value of Patient Engagement, Accountability & Next Steps
3:35PM - 4:10PM
Panel: Measuring and Demonstrating the Value of Patient Engagement Across the Medicine Lifecycle
Led By:
Beyza Klein, Director, Patient Advocacy R&D, Johnson & Johnson Innovative Medicine
4:10PM - 4:35PM
Giving Study Participants a Voice: AstraZeneca’s Journey to Scaling the Study Participant Feedback Questionnaire
Speakers:
William Dott, Director, R&D Patient Science, AstraZeneca
Showing Events in 1 Track from 04:35pm to 04:40pm
Closing Remarks
4:35PM - 4:40PM
Closing Remarks
Showing Events in 1 Track from 08:30am to 09:00am
Morning Remarks
8:30AM - 8:50AM
Registration
8:50AM - 9:00AM
Co-Chair Welcome
Co-Chairs:
Victoria DiBiaso, MPH, VP, Head of Patient Informed Development & Health Value Translation, Sanofi
Wafae Iraqi, PharmD, PhD, EMEA, Therapeutic Area Patient Engagement Lead, Johnson & Johnson Innovative Medicine
Sarah Pilkington, Director, Patient Engagement, Parexel
Alfred Samuels, Patient, Advocate and Author
Showing Events in 1 Track from 09:00am to 09:25am
Zeitgeist Discussion
9:00AM - 9:25AM
GSK on Advancing Patient-Centric Medicine Development in a Fireside Discussion
Led By:
Andrew Garvey, Global Patient Advocacy Lead, GSK
Showing Events in 1 Track from 09:25am to 10:25am
Patient Keynote, Perspectives & Collaborations
9:25AM - 9:55AM
Patient Keynote: If I Only Knew This?
Speakers:
Peter DiBiaso, Patient, Advocate
9:55AM - 10:25AM
Patient Journey Perspectives on Aspects of Vital Support
Panelists:
Peter DiBiaso, Patient, Advocate
Daniel Newman, Patient, Advocate
Temi Olonisakin, MD, Patient, Advocate
Alfred Samuels, Patient, Advocate and Author
Showing Events in 1 Track from 10:25am to 11:00am
Morning Networking Break
10:25AM - 11:00AM
Morning Networking Break
Showing Events in 1 Track from 11:00am to 12:05pm
Patient Keynote, Perspectives & Collaborations Continued
11:00AM - 11:25AM
Patient Partnerships in Action: Integrating Patient Expertise into Product Innovation and Development
Speakers:
Lorna Allen, Involvement Manager, Cystic Fibrosis Trust
Rebecca Holmes, PhD, Scientific Director, LifeArc
Connie Takawira, Partnerships Manager, Medicines Discovery Catapult
11:25AM - 11:50AM
Johnson & Johnson Innovative Medicine on an End-to-End Matrix Approach to Patient Advocacy and Engagement
Speakers:
Wafae Iraqi, PharmD, PhD, EMEA, Therapeutic Area Patient Engagement Lead, Johnson & Johnson Innovative Medicine
Beyza Klein, Director, Patient Advocacy R&D, Johnson & Johnson Innovative Medicine
11:50AM - 12:05PM
Open Session
Showing Events in 1 Track from 12:05pm to 12:50pm
Audience Breakout Session
12:05PM - 12:50PM
Mapping the Patient Journey in Clinical Trials
Led By:
Victoria DiBiaso, MPH, VP, Head of Patient Informed Development & Health Value Translation, Sanofi
Alfred Samuels, Patient, Advocate and Author
Showing Events in 1 Track from 12:50pm to 01:45pm
Lunch
12:50PM - 1:45PM
Lunch
Showing Events in 1 Track from 01:50pm to 03:00pm
DCT, DEI & Patient Recruitment Advancements
1:50PM - 2:15PM
GSK on Advances in Decentralized Clinical Trials & Engaging with Patients Digitally
Speaker:
Laura Renton, Manager (Implementation), Digital & Process Optimization, GSK
2:15PM - 2:40PM
Who are Trusted Messengers for Patient Engagement in Real World Data Studies? A Behavioural Science Approach
Speaker:
Sally Dews, Director, Global Patient Advocacy and External Partnerships, Pfizer UK
2:40PM - 3:00PM
Boehringer-Ingelheim on Overcoming Barriers to Global Diverse Recruitment in Colorectal Cancer
Speakers:
Xoli Belgrave, Executive Director, Drug Development Services, Parexel
Bert Santy, Patient & Site Engagement Lead, Boehringer Ingelheim
Nicole Sheahan, President, Global Colon Cancer Association
Showing Events in 1 Track from 03:00pm to 03:30pm
HTA Assessment/Health Technology
3:00PM - 3:30PM
Patient Involvement In Health Technology Assessment Processes – Focus On Training and Capacity Building
Speaker:
Finn McCartney, Project Manager, EUPATI
Showing Events in 1 Track from 03:30pm to 03:35pm
Stretch Break
3:30PM - 3:35PM
Stretch Break
Showing Events in 1 Track from 03:35pm to 04:35pm
Measuring Value of Patient Engagement, Accountability & Next Steps
3:35PM - 4:10PM
Panel: Measuring and Demonstrating the Value of Patient Engagement Across the Medicine Lifecycle
Led By:
Beyza Klein, Director, Patient Advocacy R&D, Johnson & Johnson Innovative Medicine
4:10PM - 4:35PM
Giving Study Participants a Voice: AstraZeneca’s Journey to Scaling the Study Participant Feedback Questionnaire
Speakers:
William Dott, Director, R&D Patient Science, AstraZeneca
Showing Events in 1 Track from 04:35pm to 04:40pm
Closing Remarks
4:35PM - 4:40PM
Closing Remarks
Next
Day 2
Wednesday, May 21, 2025

Subscribe for More Information

Please provide your contact information and select areas of interest to receive updates.